Hostname: page-component-5f745c7db-xx4dx Total loading time: 0 Render date: 2025-01-07T05:20:19.588Z Has data issue: true hasContentIssue false
  • English
  • Français

Seroprevalence of Taenia solium infections in Croatian patients presenting with epilepsy

Published online by Cambridge University Press:  01 June 2011

T. Meštrović ,
M. Sviben ,
T. Vilibić-Čavlek ,
S. Ljubin-Sternak ,
I. Tabain  and
G. Mlinarić-Galinović
T. Meštrović
Affiliation:
Polyclinic for Medical Microbiology and Parasitology ‘Dr. Zora Profozic’, Bosutska 19, 10000Zagreb, Croatia
M. Sviben*
Affiliation:
Croatian National Institute of Public Health, Microbiology Service, Rockeferellova 7, 10000Zagreb, Croatia
T. Vilibić-Čavlek
Affiliation:
Croatian National Institute of Public Health, Microbiology Service, Rockeferellova 7, 10000Zagreb, Croatia
S. Ljubin-Sternak
Affiliation:
Croatian National Institute of Public Health, Microbiology Service, Rockeferellova 7, 10000Zagreb, Croatia
I. Tabain
Affiliation:
Croatian National Institute of Public Health, Microbiology Service, Rockeferellova 7, 10000Zagreb, Croatia
G. Mlinarić-Galinović
Affiliation:
Croatian National Institute of Public Health, Microbiology Service, Rockeferellova 7, 10000Zagreb, Croatia
*
*Fax +385 1 4683 017 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Epilepsy is one of the most common neurological disorders, while neurocysticercosis caused by Taenia solium infection of the central nervous system currently represents the leading cause of secondary epilepsy in Central and South America, East and South Asia, and sub-Saharan Africa. As a result of increased migration from these endemic regions, neurocysticercosis and subsequent epilepsy are becoming a growing public health problem in developed countries as well. In order to determine the prevalence of T. solium infection in patients with epilepsy in Croatia, a retrospective serological study was conducted. A total of 770 serum samples were tested for the presence of T. solium IgG antibodies using a commercial qualitative enzyme immunoassay. The Western blot technique was used as a confirmatory test for the diagnosis. The overall seroprevalence rate of T. solium infection in patients with clinically proven epilepsy was 1.5%. Although the results have shown that infection with this tapeworm is rare in Croatia, this study hopes to increase awareness about the importance of preventive measures and benefits of accurate and timely diagnosis. Intervention measures for infection control are crucial, namely sanitation improvement, control of domestic pig-breeding, detailed meat inspection, detection and treatment of tapeworm carriers, hand washing and health education.

Type
Research Papers
Information
Journal of Helminthology , Volume 86 , Issue 3 , September 2012 , pp. 259 - 262
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carpio, A. (2002) Neurocysticercosis: an update. Lancet Infectious Diseases 2, 751–762.CrossRefGoogle ScholarPubMed
Chopra, J.S., Kaur, U. & Mahajan, R.C. (1981) Cysticercosis and epilepsy: a clinical and serological study. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 518–520.CrossRefGoogle ScholarPubMed
Commision on Tropical Diseases of the International League Against Epilepsy (1994) Relationship between epilepsy and tropical diseases. Epilepsia 35, 89–93.Google Scholar
Del Bruto, O.H., Santibanez, R., Noboa, C.A., Aguirre, R., Diaz, E. & Alarcon, T.A. (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42, 389–392.Google Scholar
Eddi, C., Nari, A. & Amanfu, W. (2003) Taenia solium cysticercosis/taeniosis: potential linkage with FAO activities; FAO support possibilities. Acta Tropica 87, 145–148.CrossRefGoogle ScholarPubMed
Flisser, A. (1994) Taeniasis and cysticercosis due to T. solium. pp. 77–116in Sun, T. (Ed.) Progress in clinical parasitology. New York, CRC Press.Google Scholar
Garcia, H.H., Gilman, R., Herrera, G., Diaz, F., Miranda, E., Gilman, R., Martinez, M., Alvarado, M., Tsang, V.C.W. & Pilcher, J.B. (1993) Cysticercosis as a major cause of epilepsy in Peru. Lancet 341, 197–200.CrossRefGoogle Scholar
Garcia, H.H., Gonzalez, A.E., Evans, C.A.W. & Gilman, R.H. (2003) Taenia solium cysticercosis. Lancet 361, 547–556.CrossRefGoogle Scholar
Gekeler, F., Eichenlaub, S., Mendoza, E.G., Sotelo, J., Hoelscher, M. & Löscher, T. (2002) Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. European Journal of Clinical Microbiology & Infectious Diseases 21, 227–229.Google Scholar
Goel, D., Dhanai, J.S., Agarwal, A., Mehlotra, V. & Saxena, V. (2011) Neurocysticercosis and its impact on crude prevalence rate of epilepsy in an Indian community. Neurology India 59, 37–40.CrossRefGoogle Scholar
Mandal, J., Singhi, P.D., Khandelwal, N. & Malla, N. (2006) Evaluation of ELISA and dot blots for the serodiagnosis of neurocysticercosis, in children found to have single or multiple enhancing lesions in computerized tomographic scans of the brain. Annals of Tropical Medicine and Parasitology 100, 39–48.CrossRefGoogle ScholarPubMed
Medina, M.T., Rosas, E., Rubio-Donnadieu, F. & Sotelo, J. (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Archives of Internal Medicine 150, 325–327.CrossRefGoogle ScholarPubMed
Palacio, L.G., Jiménez, I., Garcia, H.H., Jiménez, M.E., Sánchez, J.L., Noh, J., Ahn, L., Mora, O., Giraldo, M. & Tsang, V.C. (1998) Neurocysticercosis in persons with epilepsy in Medellín, Colombia. The Neuroepidemiological Research Group of Antioquia. Epilepsia 39, 1334–1339.CrossRefGoogle Scholar
Raccurt, C.P., Agnamey, P., Boncy, J., Henrys, J.-H. & Totet, A. (2009) Seroprevalence of human Taenia solium cysticercosis in Haiti. Journal of Helminthology 83, 113–116.CrossRefGoogle ScholarPubMed
Román, G., Sotelo, J., Del Bruto, O., Flisser, A., Dumas, M., Wadia, N., Botero, D., Cruz, M., Garcia, H.H., de Bittencourt, P.R.M., Trelles, L., Arriagada, C., Lorenzana, P., Nash, T.E. & Spina-França, A. (2000) A proposal to declare neurocysticercosis an international reportable disease. Bulletin of the World Health Organization 78, 399–406.Google ScholarPubMed
Rousseau, M.C., Guillotel, B. & Delmont, J. (1999) Neurocysticercosis in the South-East of France 1988–1998. La Presse Médicale 39, 2141–2144(in French).Google Scholar
Schantz, P.M., Wilkins, P.P. & Tsang, V.C.W. (1998) Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem. pp. 213–241in Scheld, W.M., Craig, W.A. & Hughes, J.M. (Eds) Emerging infections 2. Washington DC, ASM Press.Google Scholar
Scott, R.A., Lhatoo, S.D. & Sander, J.W. (2001) The treatment of epilepsy in developing countries: where do we go from here? Bulletin of the World Health Organization 79, 344–351.Google Scholar
Serrano Ocana, G., Ortiz Sablon, J.C., Ochoa Tamayo, I., Almaguer Arena, L., Serrano Ocana, L.M. & Govender, S. (2009) Neurocysticercosis in patients presenting with epilepsy at St Elizabeth's Hospital, Lusikisiki. The South African Medical Journal 99, 588–591.Google Scholar
White, A.C. Jr (2000) Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine 51, 187–206.Google Scholar
Willingham, A.L. 3rd & Engels, D. (2006) Control of Taenia solium cysticercosis/taeniosis. Advances in Parasitology 61, 509–566.Google Scholar